Decolonization of intestinal carriage of extended-spectrum -lactamase-producing Enterobacteriaceae with oral colistin and neomycin: a randomized, double-blind, placebo-controlled trial | Zendy

Benedikt Huttner | Zendy; Thomas Haustein | Zendy; Ilker Uçkay | Zendy; Gesuèle Renzi | Zendy; Andrew J. Stewardson | Zendy; D. Schaerrer | Zendy; A Agostinho | Zendy; Antoine Andremont | Zendy; Jacques Schrenzel | Zendy; Didier Pittet | Zendy; S. Harbarth | Zendy

Open Access

Decolonization of intestinal carriage of extended-spectrum -lactamase-producing Enterobacteriaceae with oral colistin and neomycin: a randomized, double-blind, placebo-controlled trial

Author(s) -

Benedikt Huttner,

Thomas Haustein,

Ilker Uçkay,

Gesuèle Renzi,

Andrew J. Stewardson,

D. Schaerrer,

A Agostinho,

Antoine Andremont,

Jacques Schrenzel,

Didier Pittet,

S. Harbarth

Publication year - 2013

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkt174

Subject(s) - medicine , colistin , carriage , placebo , regimen , neomycin , randomized controlled trial , nitrofurantoin , gastroenterology , antibiotics , ciprofloxacin , microbiology and biotechnology , biology , alternative medicine , pathology

Extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) are an increasingly frequent cause of infections in the community and the healthcare setting. In this study, we aimed to investigate whether intestinal carriage of ESBL-E can be eradicated.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research